HK1212436A1 - A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction - Google Patents

A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

Info

Publication number
HK1212436A1
HK1212436A1 HK16100134.9A HK16100134A HK1212436A1 HK 1212436 A1 HK1212436 A1 HK 1212436A1 HK 16100134 A HK16100134 A HK 16100134A HK 1212436 A1 HK1212436 A1 HK 1212436A1
Authority
HK
Hong Kong
Prior art keywords
diagnosing
kidney
monitoring
dysfunction
function
Prior art date
Application number
HK16100134.9A
Other languages
English (en)
Chinese (zh)
Inventor
安德里亞斯.伯格曼
Original Assignee
Sphingotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphingotec Gmbh filed Critical Sphingotec Gmbh
Publication of HK1212436A1 publication Critical patent/HK1212436A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/70Enkephalins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
HK16100134.9A 2012-10-02 2016-01-07 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction HK1212436A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12187051 2012-10-02
EP13170327 2013-06-03
PCT/EP2013/070470 WO2014053501A1 (en) 2012-10-02 2013-10-01 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

Publications (1)

Publication Number Publication Date
HK1212436A1 true HK1212436A1 (en) 2016-06-10

Family

ID=49356398

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100134.9A HK1212436A1 (en) 2012-10-02 2016-01-07 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

Country Status (12)

Country Link
US (4) US9664695B2 (da)
EP (2) EP2904403B1 (da)
JP (2) JP6307509B2 (da)
CN (1) CN104769433B (da)
CA (1) CA2886779C (da)
DK (2) DK2904403T3 (da)
ES (2) ES2810001T3 (da)
HK (1) HK1212436A1 (da)
PL (2) PL2904403T3 (da)
RU (2) RU2679913C2 (da)
TR (1) TR201809001T4 (da)
WO (1) WO2014053501A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906578B8 (en) * 2012-10-11 2019-06-26 Armaron Bio Pty Ltd Novel flavonoid compounds and uses thereof
WO2016170023A1 (en) * 2015-04-24 2016-10-27 Sphingotec Gmbh A method for predicting the risk of incidence of chronic kidney disease
WO2017200024A1 (ja) * 2016-05-17 2017-11-23 国立大学法人大阪大学 腎臓病の予後予測方法及びシステム
RU2653817C1 (ru) * 2016-11-23 2018-05-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных с инсультом
CA3065415A1 (en) * 2017-05-30 2018-12-06 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
WO2021028582A1 (en) * 2019-08-15 2021-02-18 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction in pediatric patients
RU2753588C1 (ru) * 2020-10-05 2021-08-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики доклинической стадии вторичных нефропатий у детей
RU2767701C1 (ru) * 2020-12-16 2022-03-18 Надежда Владимировна Агранович Способ ранней диагностики эндотелиальной дисфункции почек у больных хронической обструктивной болезнью легких

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634716B2 (en) 1988-08-01 1993-03-04 Ciba Corning Diagnostics Corp. Method for detection of an analyte using acridinium esters and liposomes
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
DE60238541D1 (de) 2001-08-30 2011-01-20 Biorexis Pharmaceutical Corp Modifizierte transferrin-fusionsproteine
AU2003238802A1 (en) * 2002-05-29 2003-12-19 University Of Florida Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
EP1941867B1 (en) 2002-06-07 2011-10-12 Dyax Corp. Modified kunitz domain polypeptide
EP1675878A2 (en) 2003-10-24 2006-07-05 Avidia, Inc. Ldl receptor class a and egf domain monomers and multimers
US20100028995A1 (en) 2004-02-23 2010-02-04 Anaphore, Inc. Tetranectin Trimerizing Polypeptides
WO2005114222A1 (en) * 2004-05-13 2005-12-01 Sphingo Tec Gmbh Use of precursors of enkephalins and/or their fragments in medical diagnostics
AU2005287557B2 (en) 2004-09-21 2011-10-13 Biontech Ag Use of microproteins as tryptase inhibitors
CN101680903A (zh) * 2007-03-21 2010-03-24 比奥波托诊断股份公司 肾损伤的诊断试验
ATE527353T1 (de) 2007-12-19 2011-10-15 Affibody Ab Pdgf-bindendes polypeptid aus protein a
DK2358746T3 (da) 2008-11-03 2020-12-21 Molecular Partners Ag Bindingsproteiner til inhibering af vegf-a-receptorinteraktionen
AU2009318813B2 (en) * 2008-11-21 2016-11-24 Future Medical Diagnostics Co., Ltd Methods, devices and kits for detecting or monitoring acute kidney injury
RU2550272C2 (ru) 2009-08-27 2015-05-10 Коваген Аг Новые il-17-связывающие соединения и их медицинское применение
RU2556820C2 (ru) 2009-12-14 2015-07-20 Сцил Протеинс Гмбх Модифицированные убиквитиновые белки со специфической связывающей активностью для экстрадомена "в" фибронектина
PL2580236T3 (pl) 2010-06-08 2019-09-30 Pieris Pharmaceuticals Gmbh Muteiny lipokaliny łez wiążące IL-4 R alfa
WO2012017071A1 (en) * 2010-08-06 2012-02-09 Pronota N.V. Perlecan as a biomarker for renal dysfunction
CN102636652A (zh) * 2012-04-18 2012-08-15 苏州大学 尿液中可溶性Corin在慢性肾病诊断中的应用

Also Published As

Publication number Publication date
EP3361260B1 (en) 2020-06-10
JP6669794B2 (ja) 2020-03-18
CN104769433A (zh) 2015-07-08
EP3361260A1 (en) 2018-08-15
US20150260732A1 (en) 2015-09-17
DK3361260T3 (da) 2020-08-03
JP2018141788A (ja) 2018-09-13
ES2810001T3 (es) 2021-03-08
EP2904403A1 (en) 2015-08-12
DK2904403T3 (da) 2018-07-16
US20190049470A1 (en) 2019-02-14
US10114029B2 (en) 2018-10-30
WO2014053501A1 (en) 2014-04-10
US9664695B2 (en) 2017-05-30
CA2886779C (en) 2022-11-01
TR201809001T4 (tr) 2018-07-23
PL2904403T3 (pl) 2018-08-31
CA2886779A1 (en) 2014-04-10
EP2904403B1 (en) 2018-03-28
ES2674822T3 (es) 2018-07-04
US11016107B2 (en) 2021-05-25
RU2707303C1 (ru) 2019-11-26
PL3361260T3 (pl) 2020-12-14
US20210333292A1 (en) 2021-10-28
US20170261522A1 (en) 2017-09-14
JP6307509B2 (ja) 2018-04-04
JP2015535936A (ja) 2015-12-17
RU2015116674A (ru) 2016-11-27
CN104769433B (zh) 2018-07-27
RU2679913C2 (ru) 2019-02-14

Similar Documents

Publication Publication Date Title
GB2505324B (en) A monitoring system
HK1212436A1 (en) A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
EP2778698A4 (en) BATTERY CONDITION MONITORING SYSTEM
GB2491983B (en) Vibration monitoring
GB201112161D0 (en) Portal monitoring
EP2780544A4 (en) DETERMINING OPTIMUM PARAMETERS FOR BACKGROUND OPERATION
EP2752834A4 (en) DEVICE FOR MONITORING THE VEHICLE ENVIRONMENT
GB2520670B (en) A system for monitoring a remote underwater location
GB201411337D0 (en) Seismic monitoring
EP2726835A4 (en) VIBRATION MONITORING SYSTEM
EP2929047A4 (en) METHOD FOR MONITORING THE FORMING OF SEALED GERINNSELN
GB2503610B (en) Method for monitoring seafloor movements
ZA201308885B (en) Method for automatic mutual alternation between pumps
EP2801081C0 (en) MONITORING AN OBJECT
IL232355A0 (en) A method for determining calcification tendency
EP2875234A4 (en) DIAGNOSTICS FOR A STARTING SYSTEM
HRP20200203T1 (hr) Postupak ugradnje montažne palube
SG2012068490A (en) A relay for automatically selecting a monitoring range
HK1168501A2 (en) A positioning method
HK1210749A1 (en) Method for remotely monitoring a rail vehicle
PL2691015T3 (pl) System monitorowania
GB2508750B (en) A monitoring system
GB2517558B (en) Method for monitoring an underwater site
IL240590A0 (en) A method for administering a driving test
GB201208510D0 (en) Apparatus for monitoring an offshore construction area